Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Gary Illyes says faceted navigation and action parameters dominate Google’s crawl waste, trapping bots in infinite URLs and straining servers. Google discussed its 2025 year-end report on crawling and ...

Robert McCaffrey, the husband of missing West Ashley mom Gayle McCaffrey who was at one point the prime suspect in her disappearance, has been arrested in conne Coroner identifies victim in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...